- 全部删除
- 您的购物车当前为空
PI3K-IN-59 (Compound 3d) 是一种PI3K抑制剂 (IC50: 17.44 μM),具有显著的抗增殖活性。它对乳腺癌 4T1 细胞 (IC50: 3.70 μM)、结肠癌 CT26 细胞 (IC50: 1.98 μM) 和人类乳腺癌细胞 (IC50: 19.72 μM) 表现出强效抑制作用。PI3K-IN-59 通过抑制PI3Kα酶活性并触发 Fenton 反应产生羟基自由基 (•OH),展现出双重抗肿瘤机制,并在抗 4T1 肿瘤中显示良好效果,适用于乳腺癌和结肠癌的协同靶向研究。
PI3K-IN-59 (Compound 3d) 是一种PI3K抑制剂 (IC50: 17.44 μM),具有显著的抗增殖活性。它对乳腺癌 4T1 细胞 (IC50: 3.70 μM)、结肠癌 CT26 细胞 (IC50: 1.98 μM) 和人类乳腺癌细胞 (IC50: 19.72 μM) 表现出强效抑制作用。PI3K-IN-59 通过抑制PI3Kα酶活性并触发 Fenton 反应产生羟基自由基 (•OH),展现出双重抗肿瘤机制,并在抗 4T1 肿瘤中显示良好效果,适用于乳腺癌和结肠癌的协同靶向研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
PI3K-IN-59 相关产品
产品描述 | PI3K-IN-59 (Compound 3d) is a PI3K inhibitor with an IC50 value of 17.44 μM. It demonstrates significant antiproliferative activity, showing potent inhibition against breast cancer 4T1 cells (IC50: 3.70 μM), colon cancer CT26 cells (IC50: 1.98 μM), and human breast cancer cells (IC50: 19.72 μM). The compound operates through a dual antitumor mechanism by inhibiting PI3Kα enzymatic activity and inducing hydroxyl radical (•OH) generation via the Fenton reaction. PI3K-IN-59 shows promising efficacy against 4T1 tumors, making it suitable for synergistic targeting studies in breast and colon cancer. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容